|
Your eTMF as Strategic Asset:
A Breakfast Roundtable
RSVP today to join Ken Getz, a leading academic expert in drug development research, for breakfast to hear about his latest research on trends within sponsor, CRO, and investigator relationships and sources of delay in the study start-up process. Ken answers important questions about drug development trends:
- How are outsourcing relationships changing? What's working, what's not?
- What makes outsourcing relationships fail?
- What needs to change and where is the industry headed?
Meet with thought leaders and clinical peers from leading life sciences companies to discuss the collaboration challenges that Getz identifies and to explore how to turn the eTMF into a strategic asset.
Attendance will be limited to encourage lively conversation. RSVP early to reserve your spot.
|
|
Clinical Roundtable: Your eTMF as a Strategic Asset
Featured Speakers |
 |
|
Ken Getz
Tufts Center for the Study of Drug Development
Taj Boston
15 Arlington Street
Boston, MA
Thursday, November 14th
8:30 - 11 a.m.
|
|
|
